搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Drosophila auraria Alpha-amylase-related protein (Amyrel) CSB-YP529242DLA
CSB-EP529242DLA
CSB-BP529242DLA
CSB-MP529242DLA
CSB-EP529242DLA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Apis mellifera Major royal jelly protein 2 (MRJP2) CSB-YP529243DNK
CSB-EP529243DNK
CSB-BP529243DNK
CSB-MP529243DNK
CSB-EP529243DNK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Protein pianissimo A (piaA), partial CSB-YP529244DKK
CSB-EP529244DKK
CSB-BP529244DKK
CSB-MP529244DKK
CSB-EP529244DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metapenaeus ensis Nuclear hormone receptor E75 (E75), partial CSB-YP529245MRJ
CSB-EP529245MRJ
CSB-BP529245MRJ
CSB-MP529245MRJ
CSB-EP529245MRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Plasmodium falciparum Probable inorganic pyrophosphatase (MAL3P6.3, PFC0710w) CSB-YP529246EWP
CSB-EP529246EWP
CSB-BP529246EWP
CSB-MP529246EWP
CSB-EP529246EWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhipicephalus appendiculatus Female-specific histamine-binding protein 1 CSB-YP529247RKH
CSB-EP529247RKH
CSB-BP529247RKH
CSB-MP529247RKH
CSB-EP529247RKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis UDP-glucuronosyltransferase 2B20 (UGT2B20), partial CSB-YP529248MOV1
CSB-EP529248MOV1
CSB-BP529248MOV1
CSB-MP529248MOV1
CSB-EP529248MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dog cGMP-specific 3',5'-cyclic phosphodiesterase (PDE5A), partial CSB-YP529249DO
CSB-EP529249DO
CSB-BP529249DO
CSB-MP529249DO
CSB-EP529249DO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capsicum annuum Probable 1-deoxy-D-xylulose-5-phosphate synthase, chloroplastic (TKT2), partial CSB-YP529250DQD
CSB-EP529250DQD
CSB-BP529250DQD
CSB-MP529250DQD
CSB-EP529250DQD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta 50S ribosomal protein L11, chloroplastic (rpl11) CSB-YP529251GHG
CSB-EP529251GHG
CSB-BP529251GHG
CSB-MP529251GHG
CSB-EP529251GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta 60 kDa chaperonin, chloroplastic (groL), partial CSB-YP529252GHG
CSB-EP529252GHG
CSB-BP529252GHG
CSB-MP529252GHG
CSB-EP529252GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta Uncharacterized protein ycf19 (ycf19) CSB-YP529253GHG
CSB-EP529253GHG
CSB-BP529253GHG
CSB-MP529253GHG
CSB-EP529253GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta 50S ribosomal protein L21, chloroplastic (rpl21) CSB-YP529254GHG
CSB-EP529254GHG
CSB-BP529254GHG
CSB-MP529254GHG
CSB-EP529254GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta 50S ribosomal protein L32, chloroplastic (rpl32) CSB-YP529255GHG
CSB-EP529255GHG
CSB-BP529255GHG
CSB-MP529255GHG
CSB-EP529255GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta Putative DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP529256GHG
CSB-EP529256GHG
CSB-BP529256GHG
CSB-MP529256GHG
CSB-EP529256GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta Uncharacterized protein ycf80 (ycf80) CSB-YP529257GHG
CSB-EP529257GHG
CSB-BP529257GHG
CSB-MP529257GHG
CSB-EP529257GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta Photosystem I reaction center subunit IX (psaJ), partial CSB-YP529258GHG
CSB-EP529258GHG
CSB-BP529258GHG
CSB-MP529258GHG
CSB-EP529258GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta Ferredoxin-thioredoxin reductase, catalytic chain (ftrB) CSB-YP529259GHG
CSB-EP529259GHG
CSB-BP529259GHG
CSB-MP529259GHG
CSB-EP529259GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta Photosystem I assembly protein Ycf4 (ycf4), partial CSB-YP529260GHG1
CSB-EP529260GHG1
CSB-BP529260GHG1
CSB-MP529260GHG1
CSB-EP529260GHG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guillardia theta Uncharacterized protein ycf39 (ycf39) CSB-YP529261GHG
CSB-EP529261GHG
CSB-BP529261GHG
CSB-MP529261GHG
CSB-EP529261GHG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>